Abstract
A large-scale campaign to promote measles vaccinations has substantially reduced the number of children dying from the disease in India.
Highlights
Related research article Wong BKC, Fadel SA, Awasthi S, Khera A, Kumar R, Menon G, Jha P. 2019
The measles vaccine is made of a live but weakened (’live attenuated’) form of the measles virus that can induce immunity but does not cause disease, and costs less than a dollar per dose. It was first introduced in the United States in the 1960s, and in September 2016, the World Health Organization (WHO) declared the Americas free of endemic measles
In 2010, faced with such a high mortality burden from a vaccine-preventable disease, the Indian government introduced a second dose of measles vaccine into its immunization program through a two-pronged approach: routine immunization in 17 states, and mass immunization campaigns targeting children aged between 9 months and 10 years in 14 other states with historically low immunization uptakes
Summary
Related research article Wong BKC, Fadel SA, Awasthi S, Khera A, Kumar R, Menon G, Jha P. 2019. The measles vaccine is made of a live but weakened (’live attenuated’) form of the measles virus that can induce immunity but does not cause disease, and costs less than a dollar per dose.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
